INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $210,131 | -53.5% | 4,034 | -43.4% | 0.00% | – |
| Q2 2023 | $451,534 | +34.4% | 7,131 | +15.0% | 0.00% | – |
| Q1 2023 | $335,838 | +8.0% | 6,202 | +5.6% | 0.00% | – |
| Q4 2022 | $310,905 | +0.3% | 5,875 | -11.8% | 0.00% | – |
| Q3 2022 | $310,000 | -7.7% | 6,659 | +13.1% | 0.00% | – |
| Q2 2022 | $336,000 | -7.4% | 5,890 | -0.3% | 0.00% | – |
| Q1 2022 | $363,000 | +47.6% | 5,909 | +25.6% | 0.00% | – |
| Q4 2021 | $246,000 | +103.3% | 4,705 | +45.5% | 0.00% | – |
| Q3 2021 | $121,000 | +40.7% | 3,233 | +54.2% | 0.00% | – |
| Q2 2021 | $86,000 | +3.6% | 2,096 | -13.3% | 0.00% | – |
| Q1 2021 | $83,000 | +1.2% | 2,417 | -5.0% | 0.00% | – |
| Q4 2020 | $82,000 | +24.2% | 2,545 | 0.0% | 0.00% | – |
| Q3 2020 | $66,000 | +15.8% | 2,545 | +14.4% | 0.00% | – |
| Q2 2020 | $57,000 | +62.9% | 2,224 | 0.0% | 0.00% | – |
| Q1 2020 | $35,000 | -54.5% | 2,224 | 0.0% | 0.00% | – |
| Q4 2019 | $77,000 | +413.3% | 2,224 | +7.6% | 0.00% | – |
| Q3 2019 | $15,000 | -44.4% | 2,066 | -4.4% | 0.00% | – |
| Q2 2019 | $27,000 | +12.5% | 2,161 | +4.6% | 0.00% | – |
| Q1 2019 | $24,000 | +4.3% | 2,066 | 0.0% | 0.00% | – |
| Q4 2018 | $23,000 | -48.9% | 2,066 | 0.0% | 0.00% | – |
| Q3 2018 | $45,000 | +21.6% | 2,066 | 0.0% | 0.00% | – |
| Q2 2018 | $37,000 | +1750.0% | 2,066 | +3030.3% | 0.00% | – |
| Q1 2018 | $2,000 | – | 66 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 66 | -99.8% | 0.00% | -100.0% |
| Q3 2016 | $541,000 | -61.7% | 35,482 | -2.4% | 0.00% | -50.0% |
| Q2 2016 | $1,411,000 | +6.2% | 36,367 | -23.9% | 0.00% | 0.0% |
| Q1 2016 | $1,329,000 | +1771.8% | 47,810 | +3492.0% | 0.00% | – |
| Q4 2015 | $71,000 | +26.8% | 1,331 | -4.9% | 0.00% | – |
| Q3 2015 | $56,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
| Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
| Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
| Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
| Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
| Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
| WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
| Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |